The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.
Agricultural conglomerate Cargill has co-led the first close of a $55m series D round for US-based probiotics developer Evolve BioSystems that includes medical products group Johnson & Johnson and food producer Campbell Soup.
Investment firm Manna Tree co-led the tranche with Cargill, and it also featured Spruce Capital Partners, Horizons Ventures and Bow Capital, a venture capital firm anchored by University of California.
Campbell Soup and Johnson & Johnson participated through their respective corporate venturing units, Acre Venture Partners and…
